Skip to main content

Want a detailed portfolio tracker?

Equillium (EQ) P/E (2018 - 2026)

Equillium (EQ) P/E from Oct 12, 2018 to Jul 21, 2026. The TTM Equillium (EQ) P/E is -7.00. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Equillium (EQ)

YearP/EChange
2026-7.00+141.11%
2025-2.90-11.81%
2024-3.29+7.57%
2023-3.06+551.47%
2022-0.47-83.41%
2021-2.83-24.06%
2020-3.73+62.36%
2019-2.30-79.48%
2018-11.19N/A

Comparison Equillium (EQ) P/E with competitors

Equillium (EQ) P/E is -7.00.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.06%
ENLVEnlivex Ltd0.07-101.07%
FGENFibroGen Inc0.24-103.43%
CHRSCoherus Biosciences Inc0.85-112.12%
FBIOFortress Biotech Inc0.95-113.56%
ORMPOramed Pharmaceuticals Inc1.50-121.47%
AGENAgenus Inc3.01-142.99%
INVAInnoviva Inc3.15-145.06%
VXRTVaxart Inc3.55-150.71%
CRMDCorMedix Inc3.63-151.84%
CVACCureVac N.V.4.45-163.51%
GLPGGalapagos NV4.86-169.41%
SRPTSarepta Therapeutics Inc4.88-169.74%
ABEOAbeona Therapeutics Inc5.39-176.96%
ABUSArbutus Biopharma Corp5.60-179.94%
ZVRAZevra Therapeutics Inc5.89-184.10%
SPROSpero Therapeutics Inc6.23-188.98%
CGENCompugen Ltd6.31-190.20%
RIGLRigel Pharmaceuticals6.87-198.17%
SLXNSilexion Therapeutics Corp7.30-204.23%
OMEROmeros Corporation9.26-232.27%
AUPHAurinia Pharmaceuticals Inc9.58-236.93%
PLXProtalix BioTherapeutics Inc10.89-255.59%
ACADAcadia Pharmaceuticals Inc11.73-267.55%
TBPHTheravance Biopharma Inc12.26-275.17%
ADMAAdma Biologics Inc12.42-277.40%
HRMYHarmony Biosciences Holdings Inc13.82-297.43%
SABSSAB Biotherapeutics Inc14.14-301.95%
NAGENiagen Bioscience Inc14.82-311.69%
INCYIncyte Corp15.82-326.04%
REGNRegeneron Pharmaceuticals Inc15.86-326.53%
PBYIPuma Biotechnology Inc17.32-347.37%
CPRXCatalyst Pharmaceuticals Inc17.44-349.14%
EXELExelixis Inc17.54-350.55%
TGTXTG Therapeutics Inc18.97-370.95%
MDXGMimedx Group Inc20.55-393.61%
XOMAXOMA Royalty Corp22.87-426.79%
ARGXArgen X SE24.30-447.13%
CTMXCytomX Therapeutics Inc24.82-454.60%
XOMAOXOMA Royalty Corp25.34-462.08%
HALOHalozyme Therapeutics Inc25.62-466.07%
XOMAPXOMA Royalty Corp25.67-466.73%
VRTXVertex Pharmaceuticals Inc27.99-499.94%
RPRXRoyalty Pharma plc - Class A28.69-509.84%
SLNOSoleno Therapeutics Inc29.02-514.52%
ASNDAscendis Pharma A/S30.09-529.81%
LGNDLigand Pharmaceuticals Inc - Class B37.91-641.62%
APLSApellis Pharmaceuticals Inc39.02-657.47%
BMRNBiomarin Pharmaceutical Inc42.21-703.05%
KRYSKrystal Biotech Inc45.34-747.79%
ONCBeiGene Ltd69.54-1093.47%
PHARPharming Group N.V.75.03-1171.83%
TECHBio-Techne Corp101.96-1556.60%
VCELVericel Corp109.92-1670.36%
ALNYAlnylam Pharmaceuticals Inc117.96-1785.28%
GMABGenmab140.29-2104.23%
TLXTelix Pharmaceuticals Ltd162.15-2416.55%
CORTCorcept Therapeutics Inc212.86-3140.93%